Form 4: QuidelOrtho Director Matthew Strobeck Acquires Restricted Stock Units
SEC Form 4
Director Matthew Strobeck received 4,929 restricted stock units of QuidelOrtho Corp, vesting on May 22, 2025.
Summary
- On May 22, 2024, Matthew Strobeck, a director of QuidelOrtho Corp, acquired 4,929 restricted stock units.
- These restricted stock units represent the right to receive one share of QuidelOrtho Corporation common stock each.
- The restricted stock units will vest on May 22, 2025.
- The transaction was reported on May 23, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock units granted to a director. It doesn't inherently indicate positive or negative sentiment, but rather transparency.
Positives
- The acquisition of restricted stock units by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The document does not contain any specific forward-looking statements or guidance.
Industry Context
This filing is a routine disclosure of a director's acquisition of company stock, which is common in publicly traded companies. It provides transparency into the holdings and transactions of company insiders.
Stakeholder Impact
- The acquisition of restricted stock units by a director may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/22/2024 | Date of transaction: Matthew Strobeck acquired restricted stock units. |
| 05/22/2025 | Vesting date for the restricted stock units. |
| 05/23/2024 | Date of filing the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.